Trial Review

Please note the ANZCTR will be unattended from Friday 20 December 2024 for the holidays. The Registry will re-open on Tuesday 7 January 2025. Submissions and updates will not be processed during that time.

Registering a new trial?

To achieve prospective registration, we recommend submitting your trial for registration at the same time as ethics submission.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
ACTRN12608000590369
Ethics application status
Approved
Date submitted
14/08/2008
Date registered
21/11/2008
Date last updated
21/01/2014
Type of registration
Retrospectively registered

Titles & IDs
Public title
A comparison of continuous and one-off interscalene block for pain relief following minor shoulder surgery.
Scientific title
A comparison of continuous and one-off interscalene block for postoperative analgesia following minor shoulder surgery.
Secondary ID [1] 259928 0
Nil Known
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Patients requiring postoperative analgesia following minor shoulder surgery (subacromial decompression and stabilisation) 3509 0
Condition category
Condition code
Anaesthesiology 3663 3663 0 0
Other anaesthesiology

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Interscalene block
A single operator Dr Michael Fredrickson (MF) will place all interscalene catheters (ISCs) in the operating room. Patients will be premedicated with oral acetaminophen 1 g, diclofenac SR 75 mg and omeprazole 20 mg one hour before surgery. Intravenous midazolam 2 mg, alfentanil 0.5 mg and cephazolin 1 g will be administered 5 min prior to interscalene catheter placement. Catheters will be placed following either the administration of a superficial cervical plexus block (SCPB) or after the induction of general anaesthesia depending on patient preference. ISCs will be placed using a combination of ultrasound and nerve stimulation.

General anaesthesia will then be administered and ropivacaine 0.5% 0.5 mL/kg to a maximum of 30 mL will be administered through the ISC.

Continuous block patients will then receive an ambulatory infusion of ropivacaine 0.2% at the end of surgery.
Intervention code [1] 3228 0
Treatment: Devices
Comparator / control treatment
Single shot patients will receive no infusion at the end of surgery.
Control group
Active

Outcomes
Primary outcome [1] 4567 0
Reduced pain after minor shoulder surgery, assessed by patient interrogation regarding oral analgesic consumption and pain scores using numerical rating pain score (NRPS).
Timepoint [1] 4567 0
1-2 days post operatively.
Numerical rating pain score (NRPS) measured by Post Anaesthesia Care Unit (PACU) nurse on arrival in the PACU.
Oral analgesic requirements and pain scores (0-10) measured in the afternoon of Day 1 and Day 2 following surgery
Primary outcome [2] 5001 0
Arm numbness/weakness measured by patient numerical rating scale (0-10) on postoperative day 2 questionnaire.
Timepoint [2] 5001 0
First 48 hours
Secondary outcome [1] 7720 0
Chronic pain post shoulder surgery, assessed by written questionnaire (The DASH form, Institute for Work & Health 2006) completed by patient at 3 months post operatively.
Timepoint [1] 7720 0
Day 90 post operatively

Eligibility
Key inclusion criteria
Patients undergoing elective minor shoulder surgery under the anaesthetic care of the principal investigator.
Minimum age
No limit
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
Yes
Key exclusion criteria
1. Patient refusal / inability to consent, age no limits
2. Allergy amide local anaesthetic (LA) drugs
3. Existing neurological disorders / neuropathy of the operative extremity
4. Infection at site of needle puncture
5. Severe respiratory disease
6. Chronic opioid therapy
7. Patients intolerant of all non-steroidal anti-inflammatory drugs (NSAID).

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
A invitation to participate in the study will be posted to patients identified from the operating list. One preoperative phone call will be made by the research assistant to assess patient’s suitability for the study. At this stage participation in this study would be discussed with the patient. Post operatively, patients will be questioned by phone for some simple data for the first 2 days following surgery. All patients will have a follow-up phone call at 10 days (5-10 mins) and they will be asked to fill out another questionnaire at 3 months.
Patients will be assigned to one of the two groups by random number generator, and assignments delivered in a sealed opaque envelope.
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
A computerised random number generator will be used to assign the patient to one of the 2 groups.
Masking / blinding
Blinded (masking used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Type of endpoint/s
Efficacy
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Date of first participant enrolment
Anticipated
9/07/2008
Actual
9/07/2008
Date of last participant enrolment
Anticipated
Actual
29/04/2009
Date of last data collection
Anticipated
Actual
Sample size
Target
60
Accrual to date
Final
Recruitment outside Australia
Country [1] 1099 0
New Zealand
State/province [1] 1099 0
Auckland

Funding & Sponsors
Funding source category [1] 3682 0
Government body
Name [1] 3682 0
Accident Compensation Corporation (ACC)
Country [1] 3682 0
New Zealand
Primary sponsor type
Individual
Name
Dr Michael Fredrickson
Address
Anaesthesia Institute
P O Box 109 199
Newmarket
Auckland 1149
Country
New Zealand
Secondary sponsor category [1] 3306 0
None
Name [1] 3306 0
Address [1] 3306 0
Country [1] 3306 0

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 5735 0
Northern X Regional Ethics Committee
Ethics committee address [1] 5735 0
Ethics committee country [1] 5735 0
New Zealand
Date submitted for ethics approval [1] 5735 0
Approval date [1] 5735 0
16/06/2008
Ethics approval number [1] 5735 0
NTX/08/04/027

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 28809 0
Dr Michael Fredrickson
Address 28809 0
Anaesthesia Institute
P.O. Box 109 199
Newmarket
Auckland 1149
Country 28809 0
New Zealand
Phone 28809 0
+64 9 522 1117
Fax 28809 0
Email 28809 0
anaesthesiainstitute@yahoo.com
Contact person for public queries
Name 11966 0
Michael Fredrickson
Address 11966 0
Anaesthesia Institute
P O Box 109 199
Newmarket
Auckland 1149
Country 11966 0
New Zealand
Phone 11966 0
+64 9 522 1117
Fax 11966 0
+64 9 522 1127
Email 11966 0
anaesthesiainstitute@yahoo.com
Contact person for scientific queries
Name 2894 0
Michael Fredrickson
Address 2894 0
Anaesthesia Institute
P O Box 109 199
Newmarket
Auckland 1149
Country 2894 0
New Zealand
Phone 2894 0
+64 9 522 1117
Fax 2894 0
+64 9 522 1127
Email 2894 0
anaesthesiainstitute@yahoo.com

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.